Lymphokine-activated killer cell activit
โ
Nobuya Karimine; Shigeru Nanbara; Shinya Arinaga; Tsukasa Asoh; Hiroaki Ueo; Tsu
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 661 KB
Lymphokine-activated killer (LAK) cell activity of peripheral blood mononuclear cells (PBM), spleen cells (SPC), regional lymph node cells (LNC), and tumor-infiltrating lymphocytes (TIL), induced by activation with interleukin 2 (IL 2) for 4 days, was evaluated in patients with gastric carcinoma. TI